Atorvastatin Calcium
Product Images NDC 45865-743

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Atorvastatin Calcium (NDC 45865-743). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Medsource Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Pdp (743)

Pdp (743)
This is a description of Atorvastatin Calcium Tablets that contains 10mg of medication. It is a generic version of the medication Lipitor. The text includes a number, which is likely a reference or identification number.*
FDA Label Image

Chemical Structure (Atorvastatin Calcium Tablets 1)

FDA Label Image

Figure 1 (Atorvastatin Calcium Tablets 2)

Figure 1 (Atorvastatin Calcium Tablets 2)
The available text provides a graph showing the cumulative incidence of a condition over a period of 35 years. The percentage values at 10-year intervals are 15%, 30%, and 404%. An HR (hazard ratio) of 0.64 with a confidence interval of 0.50-0.83 and a p-value of 0.0005 is also presented. The description suggests that this is a medical study evaluating the incidence of a certain condition over time.*
FDA Label Image

Figure 2 (Atorvastatin Calcium Tablets 3)

Figure 2 (Atorvastatin Calcium Tablets 3)
This is a description of a study outcome on time to the first primary endpoint in a cohort that was followed up for four years. The cumulative hazard rates (%) at years 1, 2, 3, 4, and HR with 95% confidence interval and p-value are provided. However, no information on the study design or primary endpoint is available.*
FDA Label Image

Figure 3 (Atorvastatin Calcium Tablets 4)

Figure 3 (Atorvastatin Calcium Tablets 4)
This is a table that displays the percentage of subjects who experienced a major cardiovascular event while taking either Atorvastatin 10 mg or Atorvastatin 80 mg. There is also information on the hazard ratio and the time to the first major cardiovascular endpoint.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.